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Abstract The neuronal growth-associated protein SCG10 is
enriched in the growth cones of neurons where it destabilizes
microtubules and thus contributes to the dynamic assembly and
disassembly of microtubules. Since its microtubule-destabilizing
activity is regulated by phosphorylation, SCG10 may link
extracellular signals to rearrangements of the neuronal cytoskel-
eton. To identify signal transduction pathways that may lead to
SCG10 phosphorylation, we tested a series of serine^threonine-
directed protein kinases that phosphorylate SCG10 in vitro. We
demonstrate that purified SCG10 can be phosphorylated by two
subclasses of mitogen-activated protein (MAP) kinases, c-Jun N-
terminal/stress-activated protein kinase (JNK/SAPK) and p38
MAP kinase. Moreover, SCG10 was found to bind tightly and
specifically to JNK3/SAPKL. JNK3/SAPKL phosphorylation
occurs at Ser-62 and Ser-73, residues that result in reduced
microtubule-destabilizing activity for SCG10. Endogenous
SCG10 also undergoes increased phosphorylation in sympathetic
neurons at times of JNK3/SAPKL activation following depriva-
tion from nerve growth factor. Together these observations
indicate that activation of JNK/SAPKs provides a pathway for
phosphorylation of SCG10 and control of growth cone micro-
tubule formation following neuronal exposure to cellular
stresses. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Extracellular signal-regulated kinase (ERK), c-Jun N-termi-
nal kinase/stress-activated protein kinase (JNK3/SAPKL) and
p38/RK/CSBP (p38K) represent three subclasses of mitogen-
activated protein (MAP) kinase that play an essential role
within a number of intracellular signal transduction pathways
[1^3]. Many MAP kinases are highly expressed within the
central nervous system, particularly neurons, suggesting an
important role in brain function. Recent observations suggest
involvement in at least three distinct processes. Firstly, a role
regulating neurotransmission and synaptic plasticity appears
likely as ERKs become activated during synaptic activity [4,5],
ERKs phosphorylate synapsin I at key regulatory sites [6,7],
and this MAP kinase subclass has also been shown to play an
important role in models of learning and memory [8^10]. A
second function involving MAP kinases is neuronal di¡eren-
tiation. While blockade of ERK activation prevents nerve
growth factor (NGF)-induced di¡erentiation of PC12 cells
[11], the e¡ects of this neurotrophic factor can be mimicked
by expression of mutant upstream components leading to con-
stitutive activation of ERK MAP kinases [12]. Thirdly, neuro-
nal apoptosis is also under tight control by MAP kinases, as
blocking JNK3/SAPKL, and p38 activation prevents death in
NGF-deprived PC12 cells [13,14], in sympathetic neurons [15]
and in glutamate-treated cerebellar granule cells [16], while
excitotoxic death of hippocampal neurons is blocked in mice
devoid of the JNK3 gene [17]. Powerful and rapid induction
of selected MAP kinase phosphatases during neuronal di¡er-
entiation [18] or following excitotoxic injury [19,20] is also
consistent with an important role for MAP kinases controlling
brain functions under both normal and pathological condi-
tions. One major question relating to mechanisms by which
MAP kinases may act to control di¡erent neuronal functions
is the molecular identity of target proteins undergoing phos-
phorylation and which, as a consequence, exhibit altered func-
tion.
Currently, a number of proteins are known to undergo
phosphorylation by di¡erent MAP kinases including phos-
pholipase A2, additional kinases, nuclear receptors and tran-
scription factors, as well as regulators of cell death and cyto-
skeletal function [21^25]. SCG10 is a neuron-speci¢c
membrane-associated protein highly concentrated in growth
cones that has been shown to regulate microtubule dynamics
[26]. SCG10 is found phosphorylated in brain and in vitro
studies demonstrate that this modi¢cation regulates its micro-
tubule-destabilizing activity and may be a mechanism linking
cell surface signals to altered microtubule dynamics within the
growth cone [27]. Although ERK MAP kinase p44 has been
shown to phosphorylate SCG10 [27], a comparison with other
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MAP kinases has not yet been performed. This is a critical
question as JNK3/SAPKL and p38 MAP kinases undergo
powerful activation by a number of stimuli distinct from those
that activate ERKs, including a number of in£ammatory cy-
tokines and cellular stresses. In this report, we show that
puri¢ed SCG10 can be phosphorylated not only by ERK,
but also by all three major MAP kinase classes and, more-
over, SCG10 binds tightly and speci¢cally to JNK3/SAPKL.
Together these observations could indicate a new pathway for
controlling neuronal growth cone function during in£amma-
tion or conditions of local cellular stress.
2. Materials and methods
2.1. Materials
Constitutively activated MAP kinase kinase (MEK1, JNKK2,
MKK6) and inactive MAP kinase (ERK2, JNK3/SAPKL, p38K)
were generated as GST fusion proteins in Escherichia coli and puri¢ed
using glutathione-Sepharose and nickel-agarose columns as described
[28^30]. Recombinant SCG10 was puri¢ed as described earlier and
stored in 20 mM Tris^HCl, 0.2 mM dithiothreitol (DTT), pH 7.5 at
380‡C [31]. Myelin basic protein (MBP) was from Sigma (Division of
Fluka Chemie, Buchs, Switzerland).
The following plasmids were generous gifts obtained as follows:
pcDNA1-HA-p44 ERK1 from J. Pouyssegur (CNRS, Nice, France),
pMT2T-HA-p54-SAPKL from J.R. Woodgett (Ontario Cancer Insti-
tute, Toronto, ON, Canada), pcDNA3-HA-p38 from J.S. Gutkind
(NIDR, National Institutes of Health, Bethesda, MD, USA). The
expression vectors were transfected into COS-7 cells using FuGENE6
(Roche Diagnostics AG, Basel, Switzerland). [Q-33P]ATP (1000 Ci/
mmol) and streptavidin-coated scintillation proximity assay (SPA)
beads were from Amersham Pharmacia Biotech, [Q-32P]ATP (5000
Ci/mmol) was from DuPont de Nemours International S.A. (Regens-
dorf, Switzerland). The magnetic beads, BioMag-Streptavidin were
from PerSeptive Diagnostic (Cambridge, UK), the Sulfo-NHS-LC-
Biotin from Pierce (USA). Dulbecco’s modi¢ed Eagle’s cell culture
medium and cell culture products were purchased from Life Technol-
ogies, Inc. (Basel, Switzerland), the 96-well plates (PET) were from
Wallac (Finland), and murine EGF from Promega (Madison, WI,
USA). All other chemicals were obtained from Sigma (Buchs, Switzer-
land). Sprague^Dawley rats and rat serum were supplied by Serono
Pharmaceutical Research (Geneva, Switzerland). The anti-HA mono-
clonal antibody HA.11 was from Rowag Diagnostics (Zu«rich, Switzer-
land), the anti-NGF antibody from Roche Diagnostics, rabbit anti-
GqK is described in [32] and rabbit anti-SCG10 in [27]. Horseradish
peroxidase conjugates with avidin, goat anti-mouse IgG, and goat
anti-rabbit IgG were from Bio-Rad Laboratories (Glattbrugg, Swit-
zerland).
2.2. In vitro phosphorylation assays
Phosphorylation assays were performed in 60 Wl at 30‡C for 4 h.
Reaction mixtures contained 20 Wl kinase bu¡er (50 mM HEPES pH
7.4, 20 mM MgCl2, 0.2 mM sodium vanadate, 10 mM L-glycerophos-
phate, 2 mM DTT), 10 Wl kinase substrate (15 Wg MBP, 10 Wg c-Jun,
10 Wg ATF-2 or 10 Wg SCG10), 10 Wl MAP kinase (0.6 Wg ERK2, 0.5
Wg JNK3/SAPKL, 0.5 Wg p38K) with or without 10 Wl MAP kinase
kinase (0.1 Wg MEK1, 0.2 Wg JNKK2, 0.1 Wg MKK6) and 10 Wl of
[Q-32P]ATP mix (containing 6 WCi and 56 WM unlabeled ATP in 10
mM Tris^HCl pH 7.4). Reactions were initiated by addition of the
ATP mix and incorporation of 32P radioactivity was analyzed by elec-
trophoresis on a 15% SDS^polyacrylamide gel and autoradiography.
2.3. Cell culture, transfection and stimulation
COS-7 cells were grown as previously described [28] and transfected
using FuGENE6 (Roche Diagnostics) according to the manufacturer’s
instructions. Cells were transfected with 1 Wg of the following plas-
mids: pcDNA1-HA-p44 ERK1, pMT2T-HA-p54-SAPKL, pcDNA3-
HA-p38. Cells were grown for 40 h before starvation and stimulation.
For acute stimulation of MAP kinase activation, cells were starved by
incubation in serum-free medium for 2 h followed by exposure for 10
min to EGF (10 nM), for 30 min to anisomycin (10 Wg/ml), or for 30
min to H2O2 (0.5 mM) at 37‡C.
2.4. Activation of MAP kinases in COS-7-stimulated cells and
interactions with SCG10
2.4.1. Protein biotinylation. The proteins SCG10 and c-Jun were
biotinylated according to the procedure provided by the manufacturer
(Pierce, USA). To the samples in phosphate-bu¡ered saline (PBS) was
added 3-fold molar excess of Sulfo-NHS-LC-Biotin (Pierce, USA) and
the samples were incubated at 4‡C for 2 h in roller bottles protected
from light. At the end of the incubation the samples were dialyzed
against 50% glycerol with 50 mM Tris^HCl pH 7.5, 150 mM NaCl,
0.5 mM EDTA, 0.1 mM EGTA, 5 mM DTT, 5 mM benzamidine.
The samples were stored in aliquots at 380‡C. The incorporation of
biotin was determined with the assay kit from Pierce (ImmunoPure
HABA). We incorporated 1.5 mol of biotin per mol of SCG10 and
5 mol of biotin per mol of c-Jun. For the precipitation assay (see
below), the biotinylated proteins (c-Jun-Biotin and SCG10-Biotin)
were coupled overnight by rotator mixing at 4‡C to BioMag-
Streptavidin magnetic beads as recommended by the manufacturer
(PerSeptive Diagnostics, Cambridge, UK). BioMag c-Jun and Bio-
Mag SCG10 refer to the protein-bound magnetic beads.
2.4.2. Cell lysis. The transfected and stimulated cells (as described
above) were washed twice in 2 ml of ice-cold PBS and scraped into
Eppendorf tubes with 300 Wl of Hibi lysis bu¡er (50 mM HEPES pH
7.4, containing 300 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.1%
Triton X-100, 0.5 mM DTT, 20 mM L-glycerophosphate, 0.1 mM
sodium vanadate, 2 Wg/ml leupeptin, 2 Wl/ml aprotinin, 1 mM pefa-
bloc). Cells were then homogenized using a syringe and the lysates
were stored at 380‡C until precipitation.
2.4.3. Precipitation. Aliquots (200 Wl) of the COS-7 cell lysates
were mixed with 800 Wl of Hibi dilution bu¡er (18.3 mM HEPES
pH 7.4, containing 14.2 mM NaCl, 0.07 mM EDTA, 0.03% Triton
X-100, 0.5 mM DTT, 20 mM L-glycerophosphate, 0.1 mM sodium
vanadate, 2 Wg/ml leupeptin, 2 Wg/ml aprotinin, 1 mM pefabloc) and
rotary-mixed for 1 h at 4‡C, after which time they were centrifuged at
10 000Ug for 10 min at 4‡C. For precipitation, 900 Wl of supernatant
was mixed by rotary mixing overnight at 4‡C with 100 Wl preformed
BioMag c-Jun and BioMag SCG10. The following day, the magnetic
particles were washed four times in 1 ml of ice-cold Hibi binding
bu¡er (20 mM HEPES pH 7.4, 50 mM NaCl, 2.5 mM MgCl2, 0.1
mM EDTA and 0.05% Triton X-100) followed by ¢nal resuspension
in 40 Wl of kinase bu¡er (50 mM HEPES pH 7.4, 20 mM MgCl2,
Fig. 1. In vitro phosphorylation of SCG10 by activated MAP ki-
nases. Autoradiograph of phosphorylated SCG10 and control sub-
strates (MBP, c-Jun, ATF-2) following separation on a 15% SDS^
polyacrylamide gel. Substrates were incubated with puri¢ed recombi-
nant MAP kinases (ERK2, JNK3/SAPKL or p38K) and [Q-32P]ATP
in the presence or absence of the speci¢c upstream MAP kinase ki-
nase (MEK1, JNKK2 or MKK6). All three MAP kinases phos-
phorylate SCG10.
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20 mM L-glycerophosphate, 20 mM 4-nitrophenylphosphate, 0.1 mM
sodium vanadate, 2 mM DTT). These samples were analyzed on
SDS^PAGE and Western blotting using the ECL method from Amer-
sham Pharmacia Biotech.
2.4.4. Protein complex kinase assays. Assays were performed by
mixing 20 Wl of bead suspensions with 10 Wl of [Q-32P]ATP (containing
2.5 WCi and 6 WM unlabeled ATP in 10 mM Tris^HCl pH 7.4) and 30
Wl of kinase bu¡er followed by incubation for 30 min at 30‡C. Re-
actions were terminated by adding 15 Wl of 10ULaemmli sample bu¡-
er [33] and heated for 5 min at 95‡C. Following centrifugation at
10 000Ug for 5 min, supernatants were analyzed by SDS^PAGE
(15% gels) and autoradiography.
2.5. SPA
SPA was used to measure phosphorylation of c-Jun and SCG10 as
previously described [34]. The protein kinases and the biotinylated
proteins used in this assay were as described above. To each well
(96-well plates) was added 40 Wl of assay solution containing 5 Wl of
biotinylated substrate (c-Jun-Biotin or SCG10-Biotin), 10 Wl of MAP
kinase (0.2 Wg GST-JNK3/SAPKL), 10 Wl of MAP kinase kinase
(GST-JNKK2), 10 Wl of distilled water and the reactions were initi-
ated by adding 5 Wl of kinase bu¡er (160 mM HEPES pH 7.5, 80 mM
MgCl2, 8 mM DTT, 200 mM L-glycerophosphate, 0.8 mM sodium
vanadate, 8 WM ATP, 900 nCi [Q-33P]ATP).
2.6. Analysis of SCG10 phosphopeptides and tandem mass spectrometry
(MS/MS) analysis
Puri¢ed SCG10 (100 Wg) was phosphorylated by incubation with
activated MAP kinase kinase (0.2 Wg JNKK2), inactive MAP kinase
(0.2 Wg JNK3/SAPKL), and 600 WM ATP in a total volume of 240 Wl
of kinase bu¡er (50 mM HEPES pH 7.4, 20 mM MgCl2, 20 mM
L-glycerophosphate, 20 mM 4-nitrophenylphosphate, 0.1 mM sodium
vanadate, 2 mM DTT) containing 100 WM [Q-33P]ATP (3000 dpm/
pmol). Phosphorylated SCG10 was puri¢ed by high-performance liq-
uid chromatography (HPLC), lyophilized, and digested by overnight
incubation at 37‡C in 90 Wl of 100 mM Tris^HCl pH 8.5 containing
1 M urea, 20 mM methylamine, 1 mM DTT, and 5 Wg of trypsin
(sequencing grade). Peptides were separated by reverse-phase (RP)
HPLC (Hewlett Packard HP1090) with a Brownlee C18 column
(220U2.1 mm). Peptides were eluted with an acetonitrile gradient
(in 0.1% tri£uoroacetic acid) from 0 to 55% over 60 min, followed
by 55^70% over 5 min. Fractions were collected, and radioactive
33P-labeled phosphopeptides identi¢ed by scintillation spectrometry
were sequenced by MS/MS. All MS experiments were carried out
on a Q-TOF mass spectrometer (Micromass, Manchester, UK)
equipped with a nano-electrospray ion source [35].
2.7. NGF deprivation of sympathetic neurons
Sympathetic neurons from the superior cervical ganglia (SCG) of
1-day-old Sprague^Dawley rats (supplied by Serono Pharmaceutical
Research, Geneva, Switzerland) were isolated, cultured and NGF-de-
prived as described previously [36]. The neurons were maintained for
7 days in the presence of NGF before being used for NGF with-
Fig. 2. JNK3/SAPKL binds and phosphorylates SCG10. COS-7 cells
were transfected with HA-tagged MAP kinases. After 40 h of
growth and 2 h of serum starvation, cells were incubated in the ab-
sence (^) or the presence of 10 nM EGF (HA-ERK1), 10 Wg/ml ani-
somycin (HA-SAPKL), or 0.5 mM H2O2 (HA-p38). Cells were lysed
and subjected to precipitation using biotinylated c-Jun or biotinyl-
ated SCG10 pre-bound to BioMag-Streptavidin magnetic beads. Im-
mobilized c-Jun (B) and SCG10 (C) complexes were analyzed by
Western blot using anti-HA epitope-speci¢c monoclonal antibody.
To control for expression of MAP kinases the cell lysates used for
precipitation were subjected to Western analysis using anti-HA epi-
tope monoclonal antibody (A). Data shown are representative of
three separate experiments. B, C: While all three MAP kinases are
expressed at similar amounts (A), only SAPKL becomes highly en-
riched by the precipitation indicating that SAPKL forms a complex
with c-Jun or SCG10. The anti-HA immunoreactivity seen for
ERK1 and p38 might represent non-speci¢c binding to the beads.
Quanti¢cation of the intensity of the bands on autoradiograms of
three independent experiments by optic densitometry revealed that
the gray values in lanes 3 and 4 (SAPKL) were between 2000 and
3000 times higher than the values in lanes 1 and 2 (ERK1) or lanes
5 and 6 (p38). D, E: Autoradiograph of protein complex kinase as-
says following separation on a 15% SDS^polyacrylamide gel. The
precipitated c-Jun- or SCG10-bound kinases were incubated in the
presence of [Q-32P]ATP for 30 min. Radioactivity is incorporated
into c-Jun (D) and SCG10 (E) when bound to activated JNK3/
SAPKL. Control assays (immunoprecipitation of the MAP kinases
using anti-HA epitope monoclonal antibody pre-bound to protein
Sepharose beads followed by immune complex assays using MBP,
or ATF-2 as substrates) have been performed to con¢rm activation
of ERK1 and p38 (not shown; for experimental procedures see
[29]).
Fig. 3. Time dependence of the in vitro phosphorylation of biotinyl-
ated c-Jun and SCG10 proteins. Phosphorylation of biotinylated
SCG10 and c-Jun by activated GST-JNK3/SAPKL was measured
using a 96-well plate-based SPA (n = 4), by incubating JNK3/SAPKL
with biotinylated substrate (SCG10-Biotin or c-Jun-Biotin) in the
presence of its MAP kinase kinase. The reaction was initiated with
[Q-33P]ATP and stopped at various time points by addition of 0.2
ml SPA beads solution.
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drawal. For Western blot, the growth medium from neuronal cultures
was removed after various times of NGF deprivation and the remain-
ing cells attached to the dish were harvested by scraping in a small
volume of ice-cold lysis bu¡er (20 mM HEPES, pH 7.4, 2 mM EGTA,
1% Triton X-100, 10% glycerol, 1 mM DTT, 50 mM glycerophos-
phate, 1 mM sodium orthovanadate, 10 Wg/ml leupeptin, 1 mM
PMSF, 1 Wg/ml pepstatin A, and 2 Wg/ml aprotinin), frozen in liquid
nitrogen and stored at 80‡C. The samples were heated at 90‡C in
Laemmli sample bu¡er [33], and the reaction products were separated
on a 12% SDS^polyacrylamide gel, then transferred to nitrocellulose,
and immunoblotted (ECL method of Amersham Pharmacia Biotech)
using the rabbit anti-SCG10-BR antibody [27]. This antibody which
was generated against in vitro phosphorylated (P-Ser-50, -62, -73 and
-97) recombinant SCG10 recognizes both phosphorylated and non-
phosphorylated SCG10.
3. Results and discussion
ERK1 has been reported previously to phosphorylate
SCG10 [27]. To test the activity of other MAP kinase family
members, we ¢rst incubated puri¢ed SCG10 with ERK2,
JNK3/SAPKL or p38K. Each MAP kinase was activated by
a speci¢c upstream MAP kinase kinase, MEK-1 for ERK2,
JNKK2 for JNK3/SAPKL and MKK6 for p38K. Fig. 1 shows
that all three MAP kinases undergo powerful activation by
the MAP kinase kinase and that ERK2, JNK3/SAPKL or
p38K all phosphorylate SCG10 to an extent similar to the
control substrates. The use of puri¢ed recombinant proteins
for these assays suggests that SCG10 phosphorylation results
from a direct interaction with each MAP kinase. Similar ob-
servations were made using immunopuri¢ed HA epitope-
tagged ERK1, JNK3/SAPKL and p38K following expression
and activation in COS-7 cells (data not shown).
Recently, several MAP kinases and their substrates have
been shown to form tightly bound complexes, an interaction
likely to facilitate speci¢c and rapid phosphorylation of phys-
iological target proteins within cells. This is exempli¢ed by
tight binding between JNK/SAPK family members and the
target transcription factor c-Jun [29]. To test whether
Fig. 4. MAP kinase-phosphorylated SCG10. To determine in vitro phosphorylation sites of the recombinant SCG10 after phosphorylation by
JNK3/SAPKL, the 33P-phosphorylated SCG10 was digested with trypsin and the resulting peptides puri¢ed by RP-HPLC on a C18 column.
Two peptides (A, B) eluted with the acetonitrile gradient (0^55%) in 0.1% tri£uoroacetic acid were found to be 33P-labeled. These peptides
were submitted to MS/MS analysis on a Q-TOF mass spectrometer. The yns correspond to the ions generated by cleavage of the peptide bound
after the nth amino acid from the COOH-terminal. The bns correspond to the ions generated from the NH2-terminus. The charge, when higher
than one, is indicated as superscript. The molecular weights of the identi¢ed peptide fragments are indicated in the peptide sequences. The se-
quences identi¢ed corresponded to TLASPK, residues 70^75, and RASGQAFELILKPPSPISEAPR, residues 48^69. The serine 73 and serine 62
(phosphoserine underlined) are found to be the sites of phosphorylation.
Fig. 5. Retardation of electrophoretic mobility of SCG10 expressed
in rat sympathetic neurons following NGF deprivation. The sympa-
thetic neurons were isolated and cultured as described in Section 2.
After 7 days in culture, NGF-containing medium was removed, cul-
tures were washed in NGF-free medium and incubated in medium
containing anti-NGF antibody (100 ng/ml). The protein extracts
were prepared at 0, 6, 12 and 24 h after NGF withdrawal and sepa-
rated on 12% SDS^polyacrylamide gels. Western blot analysis was
performed using the anti-SCG10-BR antiserum. Data are represen-
tative of three identical experiments.
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SCG10 is able to bind any of the major mammalian MAP
kinases, we transfected COS-7 cells with HA-ERK1, HA-
JNK3/SAPKL or HA-p38K and incubated cell lysates with
biotinylated SCG10 pre-bound to streptavidin beads. Cell ly-
sates were analyzed by Western blotting (Fig. 2A). Immobi-
lized biotinylated c-Jun was used as a control and, as antici-
pated, was found to bind and precipitate HA-JNK3/SAPKL
from cell lysates (Fig. 2B). Interestingly, immobilized SCG10
also appeared to bind strongly and selectively to HA-JNK3/
SAPKL (Fig. 2C). To test whether JNK3/SAPKL was active
when bound to SCG10, washed beads were re-suspended in
kinase bu¡er and incubated in the presence of [Q-32P]ATP.
Under these conditions, c-Jun is known to undergo phosphor-
ylation by associated JNK/SAPK enzyme [37], this is clearly
shown in Fig. 2D. In a similar fashion, SCG10 was also phos-
phorylated by bound JNK3/SAPKL derived from cells stimu-
lated by the JNK3/SAPKL activator anisomycin (Fig. 2E).
Phosphorylation of biotinylated SCG10 and c-Jun by acti-
vated JNK3/SAPKL can also be measured using a 96-well
plate-based SPA. Based on experiments using this assay, acti-
vated JNK3/SAPKL phosphorylates SCG10 approximately 5-
fold more rapidly than c-Jun (Fig. 3). Together these experi-
ments demonstrate that although all three major MAP kinase
subclasses can phosphorylate SCG10, only JNK3/SAPKL was
able to bind tightly to this substrate protein. Moreover, com-
pared with the established JNK3/SAPKL substrate c-Jun,
SCG10 represents an excellent substrate for phosphorylation
by activated JNK3/SAPKL.
Previously SCG10 residues Ser-62 and Ser-73 were shown
to be target sites for phosphorylation by the p44 ERK1 MAP
kinase [27]. To test whether JNK3/SAPKL phosphorylation
occurs at identical sites, 33P-phosphorylated SCG10 was
digested with trypsin and the resulting peptides puri¢ed using
RP-HPLC. Two peptides were found to be 33P-labeled. Se-
quencing by MS/MS (Fig. 4) identi¢ed the phosphopeptides as
TLASPK residues (70^75) and RASGQAFELILKPPSPI-
SEAPR residues (48^69), with phosphorylation at Ser-73
and Ser-62, respectively (phosphoserine underlined). These
sites are identical to those phosphorylated by p44 ERK1
suggesting that JNK3/SAPKL, as demonstrated for p44
ERK1 [31], may also be e¡ective at controlling micro-
tubule-destabilizing activity of SCG10 within neuronal growth
cones.
To assess whether SCG10 may be phosphorylated by
JNK3/SAPKL under physiological conditions, we next exam-
ined endogenous SCG10 expressed within SCG sympathetic
neurons following deprivation from NGF. Neurotrophic fac-
tor withdrawal from this cell system has been reported by
several groups to increase endogenous JNK3/SAPKL activity
and to lead to increased phosphorylation of c-Jun [38,39]. As
assessed by Western blotting, immunoreactive SCG10 bands
migrating with reduced electrophoretic mobility appear after
6^12 h of NGF removal. Such a pro¢le of reduced SCG10
migration persists for at least 24 h (Fig. 5) and is consistent
with the timing of JNK3/SAPKL activation upon trophic fac-
tor deprivation [38,39]. A similar di¡erence in the mobility of
SCG10 protein in SDS^polyacrylamide gels has previously
been observed in protein extracts of COS-7 cells transfected
with wild-type SCG10 as compared with the mutant in which
the serine phosphorylation sites have been mutated to alanines
(data not shown). Furthermore, alkaline phosphatase treat-
ment of brain extracts resulted in the disappearance of the
slower migrating bands [27]. Thus, the observed gel shift in
SCG neurons following NGF deprivation is most likely the
result of increased phosphorylation. The tight correlation with
activation of JNK3/SAPKL family members strongly suggests
that endogenous SCG10 becomes phosphorylated by this
MAP kinase under conditions of cellular stress.
In summary, this report demonstrates that all three major
classes of mammalian MAP kinase can phosphorylate the
neuronal growth cone protein SCG10, although JNK3/SAPKL
appears speci¢c insofar that it also binds tightly to this pro-
tein substrate. This could re£ect kinase^substrate complex
formation important for ensuring speci¢c SCG10 phosphory-
lation by JNK3/SAPKL under physiological conditions.
JNK3/SAPKL phosphorylation occurs at Ser-62 and Ser-73,
residues which are also phosphorylated by p44 ERK1 and
which result in reduced microtubule-destabilizing activity for
SCG10 [27]. JNK3/SAPKL is highly enriched in neurons and
activation of this MAP kinase subclass may provide a path-
way for phosphorylating SCG10 and thereby for controlling
growth cone microtubule formation following neuronal expo-
sure to in£ammatory cytokines and/or a range of cellular
stresses. Systems activating JNK3/SAPKL may regulate mi-
crotubule dynamics in concert with pathways activating other
kinases now known to phosphorylate SCG10 including p38
MAP kinase (this report), ERK, protein kinase A or p34 cdc2
kinase [27].
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